Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in NASH (LEAN)
NCT01237119Phase 2Completed
- Sponsor
- University of Birmingham
- Start
- Aug 2010
- Primary completion
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in Nonalcoholic steatohepatitis (NASH), sponsored by University of Birmingham. Started Aug 2010; status: completed.
02
Drugs
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01237119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01237119.